2,175,282 Shares in Nutrien Ltd. $NTR Acquired by Clal Insurance Enterprises Holdings Ltd

Clal Insurance Enterprises Holdings Ltd bought a new position in Nutrien Ltd. (NYSE:NTRFree Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,175,282 shares of the company’s stock, valued at approximately $138,130,000. Clal Insurance Enterprises Holdings Ltd owned 0.45% of Nutrien at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NTR. Montag A & Associates Inc. raised its stake in shares of Nutrien by 310.7% in the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after buying an additional 320 shares in the last quarter. Evolution Wealth Management Inc. acquired a new position in Nutrien during the first quarter worth about $32,000. Global Retirement Partners LLC acquired a new position in Nutrien during the second quarter worth about $30,000. Thurston Springer Miller Herd & Titak Inc. raised its position in Nutrien by 1,014.0% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company’s stock worth $30,000 after acquiring an additional 436 shares in the last quarter. Finally, Allied Private Wealth LLC bought a new stake in Nutrien in the second quarter worth about $33,000. 63.10% of the stock is owned by institutional investors.

Nutrien Trading Up 0.1%

Nutrien stock opened at $75.36 on Monday. The company has a 50 day moving average price of $66.42 and a 200 day moving average price of $70.43. Nutrien Ltd. has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a market capitalization of $36.05 billion, a price-to-earnings ratio of 15.26, a P/E/G ratio of 0.76 and a beta of 0.61.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). The firm had revenue of $10.81 billion for the quarter, compared to analyst estimates of $10.44 billion. Nutrien had a net margin of 8.44% and a return on equity of 8.88%. Nutrien’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm earned $2.65 earnings per share. Research analysts forecast that Nutrien Ltd. will post 4.95 EPS for the current year.

Nutrien Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, September 29th. Nutrien’s dividend payout ratio is currently 44.53%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on NTR shares. Oppenheimer reduced their price objective on shares of Nutrien from $82.00 to $80.00 and set an “outperform” rating for the company in a research report on Thursday, July 23rd. Berenberg Bank set a $65.00 target price on shares of Nutrien and gave the company a “hold” rating in a research note on Wednesday, June 10th. BNP Paribas Exane upgraded shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 target price for the company in a report on Tuesday, July 28th. JPMorgan Chase & Co. lifted their price target on shares of Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Finally, Scotiabank raised Nutrien from a “sector perform” rating to a “sector outperform” rating and set a $80.00 price target on the stock in a report on Tuesday, June 30th. Seventeen equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and a consensus target price of $81.58.

Check Out Our Latest Research Report on Nutrien

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.